|
EP2968373A2
|
|
Compositions and methods for treating conditions that affect epidermis
|
|
WO2013188874A1
|
|
Methods of mitigating side effects of radiation exposure and chemotherapy
|
|
US2015283233A1
|
|
Compositions and Methods for Enhancing Immune Responses
|
|
WO2013103964A1
|
|
Methods and compositions for treating proteinopathies
|
|
WO2013043580A2
|
|
Modified creatine compounds
|
|
WO2012051306A2
|
|
Compositions and methods for modulating mitochondrial proteases
|
|
US2009208478A1
|
|
Transducible polypeptides for modifying metabolism
|
|
US2009123468A1
|
|
Transducible polypeptides for modifying metabolism
|
|
CA2698755A1
|
|
Mitochondrial compositions and uses thereof
|
|
AU2007230925A1
|
|
Synthetic lipid rafts and methods of use
|
|
AU2004297533A1
|
|
Methods and compositions for delivering polynucleotides
|
|
WO2005001062A2
|
|
Modified vectors for organelle transfection
|
|
CA2512337A1
|
|
Sirna mediated post-transcriptional gene silencing of genes involved in alopecia
|
